Forest plot for univariable risk factors associated with an increased risk of cardiac event in patients who proceeded to post–doxorubicin plus cyclophosphamide therapy. Left ventricular ejection fraction (LVEF) of 65 or greater, age 50 years or younger, body mass index (BMI) of 24.9 or less, white ethnicity, and patients who did not receive radiotherapy were used as reference in each of the groups. HR, hazard ratio.